Concepedia

A.Richard Green

AG

3

Publications

177

Citations

3

H-Index

2001

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Loughborough University

A.Richard Green is an author at AstraZeneca (United Kingdom) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

MedicinePharmacologyNeuropharmacologyStrokeNeurologyBrain InjuryNeuroscienceNeuroprotectionPharmacotherapyCerebral Blood Flow

Publications per year

2001–2003

3

Publications

3

Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke

James Peeling, Marc R. Del Bigio, Dale Corbett et al. · Neuropharmacology · 2001 · 112 citations

Thrombosis, Cerebral Vascular Regulation, Reperfusion Injury +15

Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures

Jonathan Marshall, A.Richard Green, R.M. Ridley · Brain Research · 2003 · 53 citations

Cerebrovascular Disease, Pharmacotherapy, Neuroprotective Effect +17

Electrophysiological actions of γ-aminobutyric acid and clomethiazole on recombinant GABAA receptors

Rachael M Nelson, A.Richard Green, Atticus H. Hainsworth · European Journal of Pharmacology · 2002 · 12 citations

Molecular Pharmacology, Neurophysiology, Recombinant Gabaa Receptors +12

Rows per page

1–3 of 3